openPR Logo
Press release

RNA Based Therapeutics 2017 Global Market Outlook,Research,Trends and Forecast to 2022

10-03-2017 05:26 PM CET | Health & Medicine

Press release from: WiseGuy Research Consultants Pvt. Ltd.

/ PR Agency: WiseGuy Research Consultants Pvt. Ltd.
"RNA Based Therapeutics Market"

"RNA Based Therapeutics Market"

WiseGuyReports.Com Publish a New Market Research Report On - “RNA Based Therapeutics 2017 Global Market Outlook,Research,Trends and Forecast to 2022”.

This report studies the global RNA Based Therapeutics market, analyzes and researches the RNA Based Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Quark Pharmaceuticals
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals
Tekmira Pharmaceuticals
Benitec Biopharma Limited
Genzyme Corporation
ISIS pharmaceuticals
Silence Therapeutics
Cenix BioScience

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2359295-global-rna-based-therapeutics-market-size-status-and-forecast-2022

For more information or any query mail at sales@wiseguyreports.com

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, RNA Based Therapeutics can be split into
Microarrays
Labeling
Purification
Linear amplification
qRT-PCR
Inhibition
RNA Interference (RNAi) technologies
RNA antisense technologies

Market segment by Application, RNA Based Therapeutics can be split into
Cardiovascular
Kidney Diseases
Oncology
Infectious diseases
Metabolic disorders
Others

Ask Query @ https://www.wiseguyreports.com/enquiry/2359295-global-rna-based-therapeutics-market-size-status-and-forecast-2022

Table Of Contents – Major Key Points

Global RNA Based Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of RNA Based Therapeutics
1.1 RNA Based Therapeutics Market Overview
1.1.1 RNA Based Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNA Based Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 RNA Based Therapeutics Market by Type
1.3.1 Microarrays
1.3.2 Labeling
1.3.3 Purification
1.3.4 Linear amplification
1.3.5 qRT-PCR
1.3.6 Inhibition
1.3.7 RNA Interference (RNAi) technologies
1.3.8 RNA antisense technologies
1.4 RNA Based Therapeutics Market by End Users/Application
1.4.1 Cardiovascular
1.4.2 Kidney Diseases
1.4.3 Oncology
1.4.4 Infectious diseases
1.4.5 Metabolic disorders
1.4.6 Others

2 Global RNA Based Therapeutics Competition Analysis by Players
2.1 RNA Based Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Quark Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Alnylam Pharmaceuticals
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Dicerna Pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Tekmira Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Benitec Biopharma Limited
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Genzyme Corporation
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 ISIS pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Silence Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Cenix BioScience
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments

Continue…….

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2359295

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNA Based Therapeutics 2017 Global Market Outlook,Research,Trends and Forecast to 2022 here

News-ID: 753216 • Views:

More Releases from WiseGuy Research Consultants Pvt. Ltd.

Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022
Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022”. Description: The Surveillance industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Surveillance market size to maintain the average annual growth rate of 11.54% from 17980 million $ in 2014 to 24950 million $ in 2017, The analysts believe that in the
Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herrenknecht, CRTG, CRCHI, Robbins, Tianhe, Komatsu, Mitsubishi
Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herre …
WiseGuyReports.Com Publish a New Market Research Report On –“ Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herrenknecht, CRTG, CRCHI, Robbins, Tianhe, Komatsu, Mitsubishi”. Description: The Tunnel Boring Machine (TBM) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Tunnel Boring Machine (TBM) market size to maintain the average annual growth rate of 7.11% from 1880 million $ in
Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast By 2022
Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast B …
WiseGuyReports.Com Publish a New Market Research Report On –“ Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast By 2022”. Description: The Ultra Fine Copper Powder industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Ultra Fine Copper Powder market size to maintain the average annual growth rate of 5.27% from 270 million $ in 2014 to 315 million
Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022
Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022”. Description: The Car Leasing industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Car Leasing market size to maintain the average annual growth rate of X% from XXXX million $ in 2013 to XXXX million $ in 2016, The analysts believe that in the

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and